Co-Investigator: |
R826781 |
Human Health Effects of Exposure to Ultrafine Particles |
Grant |
October 1, 1998
through
September 30, 2001
|
R827354C003 |
Clinical Studies of Ultrafine Particle Exposure in Susceptible Human Subjects |
Centers |
June 1, 1999
through
May 31, 2005
|
R827354C005 |
Ultrafine Particle Cell Interactions: Molecular Mechanisms Leading to Altered Gene Expression |
Centers |
June 1, 1999
through
May 31, 2005
|
R827354C007 |
Kinetics of Clearance and Relocation of Insoluble Ultrafine Iridium Particles From the Rat Lung Epithelium to Extrapulmonary Organs and Tissues (Pilot Project) |
Centers |
June 1, 1999
through
May 31, 2006
|
R827354C008 |
Ultrafine Oil Aerosol Generation for Inhalation Studies |
Centers |
June 1, 1999
through
May 31, 2004
|
R828046 |
Pulmonary and Systemic Effects of Inhaled Ultrafine Particles in Senescent Rats with Cardiovascular Disease |
Grant |
March 24, 2000
through
March 23, 2003
|
R831722 |
Iron Oxide Nanoparticle-Induced Oxidative Stress and Inflammation |
Grant |
September 1, 2004
through
February 28, 2008
|
Principal Investigator: |
R826784 |
Lung Injury from Inhaled Ultrafine Particles in Compromised Rats of Old Age: Influence of Priming and Adaptation |
Grant |
September 1, 1998
through
September 20, 2001
|
R827354 |
Ultrafine Particles: Characterization, Health Effects and Pathophysiological Mechanisms |
Centers |
June 1, 1999
through
May 31, 2005
|
R827354C004 |
Animal Models: Dosimetry, and Pulmonary and Cardiovascular Events |
Centers |
June 1, 1999
through
May 31, 2005
|
R832415 |
Rochester PM Center: Source-Specific Health Effects of Ultrafine/Fine Particles |
Centers |
October 1, 2005
through
September 30, 2010
|
R832415C004 |
Animal models: Cardiovascular Disease, CNS Injury and Ultrafine Particle Biokinetics |
Centers |
October 1, 2005
through
September 30, 2005
|